Table 4.

Grades III to IV toxicities by CTC



Mean nos. of adverse events per patient

Cumulative incidences
Category
Nonablative (n = 60)
Ablative (n = 74)
P
Nonablative patients, % (n = 60)
Ablative patients, % (n = 74)
P
Hematologic   3.5   4.9   < .0001   100   100   .99  
Cardiovascular   0.9   1.1   0.4   68   80   .1  
Gastrointestinal   0.6   1.7   < .0001   27   80   < .0001  
Hemorrhage   0.3   0.6   .02   13   34   .005  
Hepatic   0.7   1.2   .005   48   68   .02  
Infection   1.6   2.2   .02   77   88   .09  
Metabolism   1.6   1.8   .3   72   87   .03  
Neurologic   0.6   0.5   .8   23   37   .1  
Pulmonary   0.2   0.3   .6   12   18   .4  
Renal
 
0.1
 
0.2
 
.1
 
7
 
15
 
.1
 


Mean nos. of adverse events per patient

Cumulative incidences
Category
Nonablative (n = 60)
Ablative (n = 74)
P
Nonablative patients, % (n = 60)
Ablative patients, % (n = 74)
P
Hematologic   3.5   4.9   < .0001   100   100   .99  
Cardiovascular   0.9   1.1   0.4   68   80   .1  
Gastrointestinal   0.6   1.7   < .0001   27   80   < .0001  
Hemorrhage   0.3   0.6   .02   13   34   .005  
Hepatic   0.7   1.2   .005   48   68   .02  
Infection   1.6   2.2   .02   77   88   .09  
Metabolism   1.6   1.8   .3   72   87   .03  
Neurologic   0.6   0.5   .8   23   37   .1  
Pulmonary   0.2   0.3   .6   12   18   .4  
Renal
 
0.1
 
0.2
 
.1
 
7
 
15
 
.1
 
Close Modal

or Create an Account

Close Modal
Close Modal